ClassID:

20918

A61K38/1709 - page 17 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#4801
20080182777
2008-07-31

Regulation of cell migration and adhesion

#4802
20080181893
2008-07-31

Therapeutic methods for treating vascular eye disorders with DII4 antagonists

#4803
20080181869
2008-07-31

THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE

#4804
20080178308
2008-07-24

13-transmembrane protein expressed in prostate cancer

#4805
20080176804
2008-07-24

Methods for Affecting Body Composition

#4806
20080176277
2008-07-24

Expanding the eukaryotic genetic code

#4807
20080176207
2008-07-24

Method of reducing cell death by administering a Sfrp polypeptide

#4808
20080171714
2008-07-17

Substances for preventing and treating autoimmune diseases

#4809
20080171713
2008-07-17

SUBSTANCES FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES

#4810
20080170991
2008-07-17

Selectively targeted antimicrobial peptides and the use thereof

#4811
20080167448
2008-07-10

Antibodies to tumor associated proteins

#4812
20080167246
2008-07-10

Ophthalmic and contact lens solutions containing peptides as preservative

#4813
20080166392
2008-07-10

Positive Modulator of Bone Morphogenic Protein-2

#4814
20080166356
2008-07-10

Pharmaceutical compositions and methods of using secreted frizzled related protein

#4815
20080161424
2008-07-03

Compositions and Methods for the Systemic Treatment of Arthritis

#4816
20080161262
2008-07-03

Compositions and Methods for the Systemic Treatment of Arthritis

#4817
20080161258
2008-07-03

Hsp and Supraventricular Arrhythmia

#4818
20080161239
2008-07-03

Screening method for an agent for treatment of neurodegenerative disease

#4819
20080160617
2008-07-03

AGENT FOR INDUCING EMBRYONIC STEM CELL TO ECTODERMAL CELL, METHOD FOR OBTAINING THE SAME, AND USE OF THE SAME

#4820
20080160094
2008-07-03

Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier

#4821
20080160060
2008-07-03

Methods of altering bone growth by administration of sost or wise antagonist or agonist

#4822
20080160036
2008-07-03

Compositions and methods for treating inflammation and auto-immune diseases

#4823
20080160032
2008-07-03

Compositions and methods for the systemic treatment of arthritis

#4824
20080160013
2008-07-03

METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1

#4825
20080159983
2008-07-03

Interleukin-15 antagonists for the treatment of anemia

#4826
20080152689
2008-06-26

DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS

#4827
20080152623
2008-06-26

Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)

#4828
20080146507
2008-06-19

Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor

#4829
20080146506
2008-06-19

Methods of suppressing microglial activation

#4830
20080146495
2008-06-19

Methods for Treating Hiv by Inhibiting Cd4 Down-Modulation

#4831
20080146489
2008-06-19

Regional delivery of therapeutic agents for the treatment of vascular diseases

#4832
20080145397
2008-06-19

Multi-formed collagenous biomaterial medical device

#4833
20080139460
2008-06-12

Binding agents for CD44 glycoproteins and methods of use

#4834
20080139458
2008-06-12

Methods of Treatment For Injured or Diseased Joints

#4835
20080138353
2008-06-12

Alpha B-crystallin as a therapy for rheumatoid arthritis

#4836
20080138330
2008-06-12

Methods and compositions for treating conditions involving abnormal angiogenesis

#4837
20080132446
2008-06-05

Uses of neuronal pannexins for therapy and diagnosis in mammals

#4838
20080132443
2008-06-05

Heat shock protein 20-related polypeptides and uses therefor

#4839
20080131495
2008-06-05

Mucinous glycoprotein (MUC-1) vaccine

#4840
20080131409
2008-06-05

Methods and compositions for the treatment of medical disorders

#4841
20080131400
2008-06-05

Vector system

#4842
20080131397
2008-06-05

Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

#4843
20080125370
2008-05-29

USE OF GELSOLIN TO TREAT INFECTIONS

#4844
20080124338
2008-05-29

METHODS FOR TREATMENT OF INFLAMMATORY DISEASE AND CHLAMYDIA INFECTIOUS DISEASE

#4845
20080124322
2008-05-29

Activation and inhibition of the immune system

#4846
20080124310
2008-05-29

Bead based receptor biology

#4847
20080118945
2008-05-22

USE OF GELSOLIN TO TREAT INFECTIONS

#4848
20080118514
2008-05-22

Neutralizing antibodies and methods of use thereof

#4849
20080118499
2008-05-22

Measurement of GGA proteins for diagnosing BACE associated disease

#4850
20080118466
2008-05-22

TREATMENT OF RHEUMATOID ARTHRITIS WITH SOLUBLE FAS-LIGAND CROSS-LINKERS

#4851
20080113911
2008-05-15

Methods of modulating angiogenesis

#4852
20080113909
2008-05-15

Compositions and methods for treating STAT-6 associated diseases or conditions

#4853
20080113907
2008-05-15

Uses Of Galectin-2

#4854
20080113901
2008-05-15

Use of an agent that restores tissue perfusion and oxygenation

#4855
20080112954
2008-05-15

Method for treating chronic pain

#4856
20080108550
2008-05-08

HDL for the treatment of stroke and other ischemic conditions

#4857
20080108548
2008-05-08

Food Composition For Rapidly Attenuating Inflammatory Responses

#4858
20080108066
2008-05-08

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein

#4859
20080107639
2008-05-08

Use of a Dg147 Protein Product for Preventing and Treating Metabolic Disorders

#4860
20080107637
2008-05-08

Use of an agent that restores tissue perfusion and oxygenation

#4861
20080103099
2008-05-01

Apoptin-associating protein

#4862
20080102055
2008-05-01

Method for detecting candidate alzheimer's disease drug

#4863
20080096818
2008-04-24

PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE

#4864
20080096798
2008-04-24

Method for promoting hard tissue formation

#4865
20080096794
2008-04-24

Peptide Mixture From Peptides Having A Molecular Weight Of from 1000 To 5000 Dalton

#4866
20080095835
2008-04-24

Methods for treating cancers and restenosis with P21

#4867
20080095819
2008-04-24

Composition and methods for promoting wound healing and tissue regeneration

#4868
20080095742
2008-04-24

Composition for Treating Virus Infection Disease Comprising Jab1

#4869
20080090770
2008-04-17

Modulation of Muc1 Mediated Signal Transduction

#4870
20080090766
2008-04-17

Preventive or therapeutic agents for diseases including interleukin-18 inhibitor as an active ingredient

#4871
20080089950
2008-04-17

Methods and compositions for modulating the immune system and uses thereof

#4872
20080089931
2008-04-17

EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders

#4873
20080089919
2008-04-17

Immobilized biologically active entities having a high degree of biological activity

#4874
20080085864
2008-04-10

Method of modifying glucose activity using polypeptides selectively expressed in fat tissue

#4875
20080085285
2008-04-10

Use of recombinant heat shock protein complexed to kidney cancer antigen

#4876
20080081785
2008-04-03

Antibodies to a paralytic peptide

#4877
20080081784
2008-04-03

Paralytic Peptide For Use In Neuromuscular Therapy

#4878
20080076714
2008-03-27

Administration of gene-regulatory peptides

#4879
20080076713
2008-03-27

Peptides selectively lethal to malignant and transformed mammalian cells

#4880
20080076150
2008-03-27

Process for controlling protein to salt ratio in animal muscle protein composition and protein composition

#4881
20080069823
2008-03-20

Attenuation of reperfusion injury

#4882
20080064652
2008-03-13

Methods and compositions for treating hypercholesterolemia

#4883
20080064633
2008-03-13

Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

#4884
20080064082
2008-03-13

Control of function of intracellular Ca ion

#4885
20080064026
2008-03-13

Compositions and methods for detecting and treating HIV infections

#4886
20080063637
2008-03-13

Regulation of oncogenesis by Akt-specific isoforms

#4887
20080058360
2008-03-06

Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic diseases

#4888
20080058267
2008-03-06

Apoptin-associating protein

#4889
20080057035
2008-03-06

Methods of treating various cancers using melanoma differentiation associated protein-7

#4890
20080051690
2008-02-28

Combination therapy for the treatment of Alzheimer's disease

#4891
20080051557
2008-02-28

Stable analogs of peptide and polypeptide therapeutics

#4892
20080051348
2008-02-28

TREATMENT OF INFECTIONS AND OTHER DISORDERS

#4893
20080051345
2008-02-28

Pharmaceutical compositions comprising fragments and homologs of troponin subunits

#4894
20080051342
2008-02-28

TRPS1-mediated modulation of hair growth

#4895
20080051319
2008-02-28

Inhibiting JNK Signaling Promotes CNS Axon Regeneration

#4896
20080051316
2008-02-28

Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment

#4897
20080050398
2008-02-28

Composition Comprising Beta-Defensin 2

#4898
20080045609
2008-02-21

METHODS AND THERAPEUTICS TO FACILITATE LIVER REPAIR

#4899
20080045458
2008-02-21

Paralytic Peptide For Use In Neuromuscular Therapy

#4900
20080045454
2008-02-21

Polynucleotide encoding a TRIM-Cyp polypeptide, compositions thereof, and methods of using same

#4901
20080044544
2008-02-21

Milk protein isolate and process for its preparation

#4902
20080044436
2008-02-21

Method for Screening and Compositions for Treating Cancers

#4903
20080044404
2008-02-21

Annexin V for Preventing Atherothrombosis and Plaque Rupture

#4904
20080044387
2008-02-21

ARTIFICIAL NICHES FOR ENHANCEMENT OF REGENERATIVE CAPACITY OF STEM CELLS IN AGED AND PATHOLOGICAL ENVIRONMENTS

#4905
20080044386
2008-02-21

Protamine-Adenoviral Vector Complexes and Methods of Use

#4906
20080039364
2008-02-14

Modulating serum amyloid a interaction with tanis and agents useful for same

#4907
20080038809
2008-02-14

ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES

#4908
20080026997
2008-01-31

Medicament for the treatment of fungal infections particularly aspergillosis

#4909
20080026983
2008-01-31

Compositions and methods for alleviating joint pain and improving joint flexibility

#4910
20080025982
2008-01-31

Uses of Sperm Membrane Protein Obf

#4911
20080020983
2008-01-24

Peptides with antioxidant and antimicrobial properties

#4912
20080020979
2008-01-24

Peptides of Syndecan-1 For Inhibiting Angiogenesis

#4913
20080020031
2008-01-24

Methods and compositions for altering mucus secretion

#4914
20080019987
2008-01-24

Methods of inducing IL-10 production

#4915
20080015265
2008-01-17

Methods of treating obesity using satiety factors

#4916
20080015153
2008-01-17

Pharmaceutical compositions containing the long pentraxin PTX3

#4917
20080015148
2008-01-17

IL-1 antagonist formulations

#4918
20080014636
2008-01-17

Tumor antigen protein and use thereof

#4919
20080014206
2008-01-17

Targeting of triacylglycerol synthase gene for tuberculosis treatment

#4920
20080009459
2008-01-10

Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences

#4921
20080008688
2008-01-10

System and method for genetically treating cardiac conduction disturbances

#4922
20080004232
2008-01-03

Characterization of c19orf10, a Novel Synovial Protein

#4923
20080004231
2008-01-03

Retinal dystrophy-associated protein and uses thereof

#4924
20070299245
2007-12-27

P277 PEPTIDE FORMULATIONS OR VARIANTS THEREOF HAVING OPTIMIZED STABILITY

#4925
20070299031
2007-12-27

THERAPEUTIC AGENT FOR TUMOR OF NEURAL ORIGIN

#4926
20070299011
2007-12-27

APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER

#4927
20070299010
2007-12-27

CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists

#4928
20070299005
2007-12-27

Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof

#4929
20070299002
2007-12-27

Alpha-1-acid glycoprotein for the treatment of diabetes

#4930
20070298012
2007-12-27

Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules

#4931
20070293453
2007-12-20

Combinatorial Methods For Inducing Cancer Cell Death

#4932
20070293431
2007-12-20

METHOD FOR IMPROVING NEUROTRANSMISSION FAILURE USING A NOVEL AGENT

#4933
20070292496
2007-12-20

Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics

#4934
20070292412
2007-12-20

Genes and markers in type 2 diabetes and obesity

#4935
20070286848
2007-12-13

Epas1 Gene Transfer to Improve Cell Therapy

#4936
20070286806
2007-12-13

Methods and Compositions for Modulating a Steroid Receptor

#4937
20070280997
2007-12-06

Composition for enhancing muscle recovery

#4938
20070280954
2007-12-06

Nogo epitopic fragments for modulating immune response

#4939
20070280903
2007-12-06

T1 Receptor-Like Ligand II and Uses Thereof

#4940
20070275893
2007-11-29

COMPOSITIONS FOR ENHANCED EPITHELIAL PERMEATION OF PEPTIDE YY FOR TREATING OBESITY

#4941
20070275890
2007-11-29

Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion

#4942
20070275036
2007-11-29

AVIAN FOLLISTATIN PRODUCT

#4943
20070270369
2007-11-22

Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis

#4944
20070270346
2007-11-22

COMPOSITIONS AND METHODS COMPRISING PROSTAGLANDIN-RELATED COMPOUNDS AND TREFOIL FACTOR FAMILY PEPTIDES FOR THE TREATMENT OF GLAUCOMA WITH REDUCED HYPEREMIA

#4945
20070270331
2007-11-22

Modulators of gluconeogenesis

#4946
20070269890
2007-11-22

Compositions of active Wnt protein

#4947
20070269452
2007-11-22

Methods and compositions for the diagnosis and treatment of cancer

#4948
20070265196
2007-11-15

Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein

#4949
20070264321
2007-11-15

Method of treating skin ulcers with vectors encoding hepatocyte growth factor

#4950
20070259818
2007-11-08

Methods and compositions for treating conditions

#4951
20070259425
2007-11-08

Method of enhancing cardiac tissue repair by administering a SFRP polypeptide

#4952
20070258951
2007-11-08

Methods of treating cardiac disorders

#4953
20070256149
2007-11-01

Dep2 and its uses in major depressive disorder and other related disorders

#4954
20070256148
2007-11-01

DEP2 and its uses in major depressive disorder and other related disorders

#4955
20070254832
2007-11-01

Methods for the treatment of macular degeneration and related eye conditions

#4956
20070254364
2007-11-01

Methods and compositions for treating disorders involving excitotoxicity

#4957
20070253904
2007-11-01

Methods of treating diabetes

#4958
20070253896
2007-11-01

7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors

#4959
20070249557
2007-10-25

Compositions and methods for viscosupplementation

#4960
20070249534
2007-10-25

Novel medicament for treating neurodegenerative diseases

#4961
20070249528
2007-10-25

Histamine Binding Compounds for Treatment Method for Disease Conditions Mediated by Neutrophils

#4962
20070248676
2007-10-25

Use of nitric oxide adducts

#4963
20070248609
2007-10-25

Method of modulating inflammatory response by downregulation of activin

#4964
20070248607
2007-10-25

NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY NKG2D-POSITIVE CD4+ CELLS

#4965
20070248599
2007-10-25

TREATMENT OF ALZHEIMER'S DISEASE WITH INHIBITORS OF APOE BINDING TO APOE RECEPTOR

#4966
20070248597
2007-10-25

Methods of decreasing vascular calcification using IL-1 inhibitors

#4967
20070248579
2007-10-25

Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome

#4968
20070244052
2007-10-18

Methods for Identifying Agonists or Antagonists of CD200R Signaling Molecules and Methods of Using the Same

#4969
20070244051
2007-10-18

Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia

#4970
20070244033
2007-10-18

METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN

#4971
20070243226
2007-10-18

Methods of producing growth factor complex

#4972
20070243214
2007-10-18

Genes and proteins associated with angiogenesis and uses thereof

#4973
20070243179
2007-10-18

Methods for treating diseases and increasing longevity

#4974
20070238668
2007-10-11

Methods of using gelsolin to treat or prevent bacterial sepsis

#4975
20070238666
2007-10-11

Peptides selectively lethal to malignant and transformed mammalian cells

#4976
20070238655
2007-10-11

Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis

#4977
20070238649
2007-10-11

Agents for Regulating Adiponectin Receptor Expression

#4978
20070238645
2007-10-11

Regulators of the non-genomic action of progesterone and methods of use

#4979
20070238643
2007-10-11

P62 as a diagnostic tool for alzheimer's disease

#4980
20070238641
2007-10-11

Pharmaceutical combined preparation containing a therapeutic protein

#4981
20070237780
2007-10-11

Method of preventing or reducing the risk or incidence of cancer

#4982
20070237753
2007-10-11

Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene

#4983
20070232556
2007-10-04

Methods and compositions for the treatment of neurological diseases and disorders

#4984
20070232539
2007-10-04

Lipid therapy

#4985
20070231842
2007-10-04

DETECTION OF AUTOANTIBODIES TO CYTOKERATIN 18 PROTEIN IN PATIENTS WITH BRONCHIAL ASTHMA AND CHRONIC RHINITIS

#4986
20070231401
2007-10-04

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#4987
20070231341
2007-10-04

Cat dander allergen treatments

#4988
20070231304
2007-10-04

PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY

#4989
20070225315
2007-09-27

Methods of treating muscular wasting diseases using NF-κB activation inhibitors

#4990
20070225264
2007-09-27

Drug delivery means

#4991
20070225240
2007-09-27

Screening Assay and Treatment

#4992
20070219136
2007-09-20

Methods and compositions for treating inflammatory disorders

#4993
20070213266
2007-09-13

Methods for using and identifying modulators of Delta-like 4

#4994
20070212701
2007-09-13

Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof

#4995
20070207969
2007-09-06

Treatment of cancers of lymphocytic cells with product R

#4996
20070207953
2007-09-06

Host Defense Factor X (HDFX)

#4997
20070207209
2007-09-06

Trophic factor combinations for nervous system treatment

#4998
20070207150
2007-09-06

MODIFIED ANNEXIN PROTEINS AND METHODS FOR THEIR USE IN ORGAN TRANSPLANTATION AND IN PREVENTION OF THROMBOSIS AND REPERFUSION INJURY

#4999
20070203088
2007-08-30

Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease

#5000
20070203067
2007-08-30

Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties

#5001
20070202134
2007-08-30

Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced Apoptosis

#5002
20070202096
2007-08-30

XAF genes and polypeptides: methods and reagents for modulating apoptosis

#5003
20070202081
2007-08-30

Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano

#5004
20070197442
2007-08-23

Methods for the Treatment of Macular Degeneration and Related Eye Conditions

#5005
20070197428
2007-08-23

Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals

#5006
20070191269
2007-08-16

Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility

#5007
20070191268
2007-08-16

Recombinant lubricin molecules and uses thereof

#5008
20070191265
2007-08-16

Anti-HIV Agent

#5009
20070190652
2007-08-16

Anti-HIV Agent

#5010
20070190575
2007-08-16

Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation

#5011
20070190572
2007-08-16

Methods and kits using a molecular interaction between a Smurf-1 WW domain and LIM mineralization protein isoforms

#5012
20070190040
2007-08-16

Recombinant p53 adenovirus methods and compositions

#5013
20070190030
2007-08-16

Method of treating arthritis using lentiviral vectors in gene therapy

#5014
20070185022
2007-08-09

Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products

#5015
20070185019
2007-08-09

Novel antimicrobial peptides with heparin binding activity

#5016
20070184477
2007-08-09

Anti-HIV Agent

#5017
20070184058
2007-08-09

Glucocerebroside treatment of pulmonary or respiratory diseases or disorders

#5018
20070183983
2007-08-09

Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same

#5019
20070183975
2007-08-09

Polypeptide absorbable into digestive organs

#5020
20070179087
2007-08-02

METHOD FOR TREATING INFLAMMATORY DISEASES USING HEAT SHOCK PROTEINS

#5021
20070178075
2007-08-02

Side population cells in cardiac repair

#5022
20070178066
2007-08-02

PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS

#5023
20070173456
2007-07-26

PREPTIN FRAGMENTS AND METHODS OF USE

#5024
20070173454
2007-07-26

Methods for slowing senescence and treating and preventiing diseases associated with senescence

#5025
20070173439
2007-07-26

Methods for treating interleukin-18 mediated disorders with interleukin-18 binding proteins

#5026
20070172474
2007-07-26

Dairy components effective for fat loss

#5027
20070172467
2007-07-26

Treatment of tumor with dnazyme directed to peroxiredoxin

#5028
20070169210
2007-07-19

Methods and compositions for modulating gamete adhesion

#5029
20070167611
2007-07-19

Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function

#5030
20070167351
2007-07-19

Peptide/Lipid Complex Formation by Co-Lyphilization

#5031
20070166791
2007-07-19

Expanding the eukaryotic genetic code

#5032
20070166710
2007-07-19

Methods for inhibiting adipogenesis and for treating type 2 diabetes

#5033
20070166359
2007-07-19

HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing

#5034
20070161584
2007-07-12

Drug for preventing or treating heart diseases comprising CD9 gene

#5035
20070161566
2007-07-12

Method of treating multiple sclerosis

#5036
20070161557
2007-07-12

Casein derived peptides and uses thereof in therapy

#5037
20070160573
2007-07-12

Peptide conjugated anti-cancer prodrugs

#5038
20070160558
2007-07-12

Peptide composition

#5039
20070155689
2007-07-05

METHODS OF REGULATING GROWTH AND DEATH OF CANCER CELLS

#5040
20070154952
2007-07-05

Expanding the eukaryotic genetic code

#5041
20070154529
2007-07-05

Uses of dna binding proteins

#5042
20070154457
2007-07-05

Use of eIF-5A to kill multiple myeloma cells

#5043
20070149483
2007-06-28

Methods and compounds for modulating triglyceride and vldl secretion

#5044
20070149453
2007-06-28

Biological agent that causes IL-6 receptor release

#5045
20070149448
2007-06-28

Use of the cathelicidin LL-37 and derivatives thereof for wound healing

#5046
20070148150
2007-06-28

MKK7 activation inhibitor

#5047
20070142314
2007-06-21

Decoy-containing pharmaceutical compositions and method of using the same

#5048
20070142289
2007-06-21

Use of insulin-like growth factor binding protein 3 (IGF-BP3) for inhibition of tumor growth

#5049
20070142276
2007-06-21

Protein involved in carcinoma

#5050
20070141023
2007-06-21

Assays and methods using biomarkers

#5051
20070135382
2007-06-14

Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions

#5052
20070134664
2007-06-14

Human autism susceptibility gene and uses thereof

#5053
20070134654
2007-06-14

Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated PP2Ac

#5054
20070134291
2007-06-14

Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition

#5055
20070134261
2007-06-14

Effectors of innate immunity

#5056
20070134260
2007-06-14

Use of clusterin for the treatment and/or prevention of peripheral neurological diseases

#5057
20070134258
2007-06-14

GASP1: a follistatin domain containing protein

#5058
20070134227
2007-06-14

Catalyst for cleaving sugar chain

#5059
20070129307
2007-06-07

Insulin epitopes for the treatment of type 1 diabetes

#5060
20070128667
2007-06-07

Secreted neural apoptosis inhibiting proteins

#5061
20070128303
2007-06-07

Anti-inflammatory, cytoprotective factor derivable from a probiotic organism

#5062
20070128259
2007-06-07

AL-2 neurotrophic factor

#5063
20070128188
2007-06-07

Isolated stra6 polypeptides

#5064
20070128184
2007-06-07

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins

#5065
20070128159
2007-06-07

CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE

#5066
20070124825
2007-05-31

Hepcidin inhibitors for regulating iron homeostasis

#5067
20070122379
2007-05-31

COMBINED TUMOR SUPPRESSOR GENE THERAPY AND CHEMOTHERAPY IN THE TREATMENT OF NEOPLASMS

#5068
20070122378
2007-05-31

Methods and compositions for the treatment of persistent infections

#5069
20070117753
2007-05-24

Conversion of apoptotic proteins

#5070
20070116694
2007-05-24

Inhibitor of interaction of granzyme b with golgin-160

#5071
20070116688
2007-05-24

Hox11+, CD45− cells and methods of organ regeneration using the same

#5072
20070116645
2007-05-24

Methods and compositions for inhibiting cholesterol uptake

#5073
20070111936
2007-05-17

Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer

#5074
20070111933
2007-05-17

Diagnosis and treatment methods related to aging, especially of liver

#5075
20070110828
2007-05-17

Use of NF-B inhibition in combination therapy for cancer

#5076
20070110760
2007-05-17

Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity

#5077
20070110728
2007-05-17

Method for preventing and treating diabetes using dg119

#5078
20070110710
2007-05-17

Treatment with immunoregulatory t cells

#5079
20070110698
2007-05-17

Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto

#5080
20070107073
2007-05-10

Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome

#5081
20070105776
2007-05-10

Compositions of active Wnt protein

#5082
20070105751
2007-05-10

Use of NF-κB inhibition in combination therapy for cancer

#5083
20070105224
2007-05-10

Genetic modification of liver cells to enhance metabolic and physiological efficacy

#5084
20070104722
2007-05-10

Targeted biocides

#5085
20070098828
2007-05-03

Methods and compositions for the prevention and regression of neovascularization

#5086
20070098735
2007-05-03

Methods for the Elimination of Pathogens and Other Particulate Agents

#5087
20070098725
2007-05-03

Antibodies against a peptide epitope of apolipoprotein B

#5088
20070098722
2007-05-03

Medicament comprising inhibitors of long pentraxin ptx3

#5089
20070098721
2007-05-03

Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

#5090
20070098709
2007-05-03

Methods for treating and preventing diabetic retinopathy

#5091
20070098707
2007-05-03

Methods and Compositions for Inhibiting C-MET Dimerization and Activation

#5092
20070098690
2007-05-03

Truncated CMV promoters and vectors containing same

#5093
20070093444
2007-04-26

Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes

#5094
20070092912
2007-04-26

USES OF HUMAN ZVEN ANTAGONISTS

#5095
20070092527
2007-04-26

Proton-sensing g-protein coupled receptors and dna sequences thereof

#5096
20070087992
2007-04-19

Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof

#5097
20070087970
2007-04-19

Use of C-reactive protein to treat immune complex-mediated renal disease

#5098
20070087969
2007-04-19

Wound healing and treatment of fibrosis

#5099
20070087968
2007-04-19

Methods to treat T-cell disorders using TISF

#5100
20070087414
2007-04-19

Isolated nucleic acid sequence comprising SEQ ID NO: 14 and methods of using said nucleic acid sequence